Peter L. Choyke
Molecular Biology · 2003–2020
A researcher in the Science corpus: 21 papers; trusts 5 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 50 citations into it; #7,442 of 17,773 by trust here, #5,550 by citations
- Oncology — 46 citations into it
- Biomedical Engineering — 32 citations into it; #2,809 of 10,734 by trust here, #1,760 by citations
- Cancer Research — 25 citations into it
- Biomaterials — 17 citations into it
- Immunology and Allergy — 10 citations into it
Whom Peter L. Choyke trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Peter L. Choyke overall
Papers from Peter L. Choyke's perspective
Ordered by how strongly the researchers Peter L. Choyke trusts endorse each paper. Same corpus, a different order for every researcher.
- ImageNet classification with deep convolutional neural networks
- Going deeper with convolutions
- Fully convolutional networks for semantic segmentation
- U-Net: Convolutional Networks for Biomedical Image Segmentation (International Conference on Medical Image Computing and Computer-Assisted Intervention)
- Multi-column deep neural networks for image classification
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Deeply-Supervised Nets
- Deep Residual Learning for Image Recognition (Computer Vision and Pattern Recognition)
- Deep Neural Networks Segment Neuronal Membranes in Electron Microscopy Images
Their papers
- Deeply-supervised CNN for prostate segmentation (2017) — 217 citations
- Imaging of angiogenesis: from microscope to clinic (2003) — 1,067 citations
- Clearance Properties of Nano-sized Particles and Molecules as Imaging Agents: Considerations and Caveats (2008) — 1,957 citations
- Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. (2003) — 606 citations
- Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules (2011) — 951 citations
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma (2011) — 808 citations
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? (2016) — 938 citations
- New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging (2010) — 1,965 citations
- Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes (2009) — 753 citations
- MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. (2020) — 757 citations
- Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets (2020) — 535 citations
- Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. (2019) — 2,260 citations
- Automatic magnetic resonance prostate segmentation by deep learning with holistically nested networks (2017) — 66 citations
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 (2015) — 2,906 citations
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer (2015) — 1,517 citations
- Computer Aided-Diagnosis of Prostate Cancer on Multiparametric MRI: A Technical Review of Current Research (2014) — 118 citations
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target? (2013) — 915 citations
- ESUR prostate MR guidelines 2012 (2012) — 2,428 citations
- Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. (2009) — 2,018 citations
- Imaging prostate cancer: a multidisciplinary perspective. (2007) — 625 citations